Sidi Chen, PhD
Affiliations: | 2004-2011 | University of Chicago, Chicago, IL | |
| 2009-2009 | Stanford University, Palo Alto, CA | ||
| 2011-2015 | Massachusetts Institute of Technology, Cambridge, MA, United States | ||
| 2012-2015 | Broad Institute, Cambridge, MA, United States | ||
| 2015- | Yale University, New Haven, CT |
Area:
Molecular biology, cancer, gene editing, genomics, evolution, immunologyWebsite:
sidichenlab.orgGoogle:
"Sidi Chen"Parents
Sign in to add mentor| Manyuan Long | grad student | 2005-2011 | Yale | |
| (Origin of essential functions and evolution of phenotypes.) | ||||
| Phillip Allen Sharp | post-doc | 2011-2015 | MIT / Koch Institute (Chemistry Tree) | |
| Feng Zhang | research scientist | 2012-2015 | MIT (Neurotree) | |
| (visiting postdoc / collaborating postdoc) | ||||
Children
Sign in to add trainee| Matthew B. Dong | grad student | 2015-2021 | Johns Hopkins |
| Ryan D. Chow | grad student | 2017-2022 | Penn |
| Jonathan J. Park | grad student | 2017-2022 | Yale |
| Guangchuan Wang | post-doc | 2016-2020 | Shanghai institute of biochemistry and cell biology |
| Lupeng Ye | post-doc | 2017-2022 | Nanjing University |
| Xiaoyun Dai | post-doc | 2016-2023 | Westlake University |
| Quanjun Yang | research scientist | 2018-2021 | Shanghai JiaoTong University |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Baysoy A, Tian X, Zhang F, et al. (2024) Spatially Resolved CRISPR Screen Sequencing via Perturb-DBiT. Biorxiv : the Preprint Server For Biology |
| Peng L, Sferruzza G, Yang L, et al. (2024) CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors. Cellular & Molecular Immunology |
| Dong C, Zhang F, He E, et al. (2024) Sensitive detection of synthetic response to cancer immunotherapy driven by gene paralog pairs. Biorxiv : the Preprint Server For Biology |
| Peng L, Renauer PA, Sferruzza G, et al. (2024) In vivo AAV-SB-CRISPR screens of tumor-infiltrating primary NK cells identify genetic checkpoints of CAR-NK therapy. Nature Biotechnology |
| Verma N, Renauer PA, Dong C, et al. (2024) Genome scale CRISPR screens identify actin capping proteins as key modulators of therapeutic responses to radiation and immunotherapy. Biorxiv : the Preprint Server For Biology |
| Zhou L, Yang L, Feng Y, et al. (2023) Pooled screening with next-generation gene editing tools. Current Opinion in Biomedical Engineering. 28 |
| Barish S, Berg K, Drozd J, et al. (2023) The H2Bub1-deposition complex is required for human and mouse cardiogenesis. Development (Cambridge, England). 150 |
| Zhou X, Cao H, Fang SY, et al. (2023) CTLA-4 tail fusion enhances CAR-T antitumor immunity. Nature Immunology |
| Zhou X, Renauer PA, Zhou L, et al. (2023) Applications of CRISPR technology in cellular immunotherapy. Immunological Reviews |
| Ye L, Lam SZ, Yang L, et al. (2023) AAV-mediated delivery of a Sleeping Beauty transposon and an mRNA-encoded transposase for the engineering of therapeutic immune cells. Nature Biomedical Engineering |